- Home
- NTSK vs TERN Comparison
NTSK vs TERN Comparison
Compare NTSK & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.18
HOLD
Current Price
$41.69
Company Overview
Basic Information| Metric | NTSK | TERN |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.5B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTSK | TERN |
|---|---|---|
| Price | $10.18 | $41.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $24.86 | ★ $48.60 |
| AVG Volume (30 Days) | ★ 2.5M | 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.91 | N/A |
| Revenue Next Year | $23.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.13 | $1.87 |
| 52 Week High | $24.98 | $48.26 |
Technical Indicators
Market Signals| Indicator | NTSK | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 35.53 | 64.00 |
| Support Level | $9.13 | $39.15 |
| Resistance Level | $16.75 | $48.26 |
| Average True Range (ATR) | 0.89 | 2.17 |
| MACD | 0.11 | 0.26 |
| Stochastic Oscillator | 31.92 | 79.69 |
Price Performance
Historical Comparison NTSK
TERN
About NTSK Netskope Inc.
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security and networking services to enable fast and secure AI, cloud, and web access at the edge.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.